Assistant Professor, Oncologic Sciences, USF-Morsani
Hematology
Dr. Tawee Tanvetyanon, MD
|
|
Give Review
Dr. Tawee Tanvetyanon practices Hematology. Tawee Tanvetyanon is also published. He has 67 publications published. The lastest publication: "Changes in the Care of Non-Small-Cell Lung Cancer After Audit and Feedback: The Florida Initiative for Quality Cancer Care.' Tawee Tanvetyanon accepts Medicare payments and is registered with Medicare.gov.
Publications
- Changes in the Care of Non-Small-Cell Lung Cancer After Audit and Feedback: The Florida Initiative for Quality Cancer Care.
- Repeat Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy May Offer Survival Benefit for Intraperitoneal Mesothelioma: A Single Institution Experience.
- Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous Cell carcinoma.
- Variance of SUVs for FDG-PET/CT is Greater in Clinical Practice Than Under Ideal Study Settings.
- Effect of prophylactic fluconazole on oral mucositis and candidiasis during radiation therapy for head-and-neck Cancer.
- Metastatectomy for extra-cranial extra-Adrenal non-small cell lung cancer solitary metastases: systematic review and analysis of reported cases.
- Relationship of exercise to quality of life in Cancer patients beginning chemotherapy.
- Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage ...
- Relationship between tumor size and survival among patients with resection of multiple synchronous lung Cancers.
- Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung Cancer.
- Quality-of-care indicators for non-small cell lung Cancer.
- Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary Gland carcinoma.
- Prognostic factors for survival after salvage reirradiation of head and neck Cancer.
- Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab.
- Cetuximab in head and neck Cancer.
- Survival outcomes of squamous cell carcinoma arising from sinonasal inverted papilloma: report of 6 cases with systematic review and pooled Analysis.
- Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung Cancer.
- Computed tomography response, but not positron emission tomography scan response, predicts survival after neoadjuvant chemotherapy for resectable non-small-Cell lung c...
- Beta-carotene in multivitamins and the possible risk of lung Cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands.
- Outcomes of Adrenalectomy for isolated synchronous versus metachronous Adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis.
- A systematic review of quality of life associated with standard chemotherapy regimens for advanced non-small cell lung Cancer.
- Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung Cancer.
- Physician practice in the discontinuation of statins among patients with advanced lung Cancer.
- Understanding the uncommon thoracic Tumors.
- Commentary: concomitant chemotherapy and radiation for limited stage small cell lung Cancer and benefit of adding additional drug into chemotherapy regimen for advance...
- Acute lung injury associated with vinorelbine.
- Management of the adverse effects associated with intravenous bisphosphonates.
- Severity, risk factors, and physician practices in the management of Anemia during concurrent chemoradiation for head and neck carcinoma.
- Consideration before administering cytotoxic chemotherapy to the critically ill.
- Reply to the article "The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate Cancer" by K. P. Weinfurt...
- Medical costs associated with chiropractic care.
- Treatment of localized Lymphoma.
- Molecular prediction of recurrence of breast Cancer.
- Development of malignant mesothelioma during treatment for prolymphocytic Leukemia: is asbestos or simian virus 40 a link?
- Neoadjuvant therapy: an emerging concept in oncology.
- Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall Cell lung carcinoma and other solid tumors.
- Talking about death with dying children.
- Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate Cancer.
- Recurrent steroid-responsive pancreatitis associated with myelodysplastic Syndrome and transformations.
- Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy.
- Telephone psychotherapy and care management for depression.
- Treatment of von Willebrand's Disease.
- Re: Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate Cancer.
- Pancytopenia in hereditary haemorrhagic telangiectasia.
- Arterial thrombosis in Systemic lupus erythematosus.
- Which patient with a do-not-intubate order is a candidate for noninvasive ventilation?
- Mucoepidermoid Carcinoma of the lung presenting as a cavitary lesion.
- Proton pump inhibitors and iron deficiency: is the connection real?
- Second allogeneic transplantation using a reduced-intensity preparative regimen for relapsed myelofibrosis.
- Post-transplant air-leak Syndrome.
- Is hypocalcemia during therapy with zoledronic acid or other bisphosphonates beneficial to Cancer patients?
- HER-2 and fluorescent in situ hybridization to evaluate breast Cancer.
- Adjuvant treatment of breast Cancer with exemestane.
- Herpes zoster during treatment with arsenic trioxide.
- Screening for primary human immunodeficiency virus infection.
- Fatal Acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade.
- Hypocalcemia and azotemia associated with zoledronic acid and interferon alfa.
- Overcoming recurrent cutaneous reactions from imatinib using once-weekly dosing.
- The European Organization for Research and Treatment of Cancer quality of life questionnaire: translation and reliability study of the Thai version.
- Life-sustaining treatments in patients who died of chronic congestive heart failure compared with metastatic Cancer.
- Octreotide for bleeding as a result of hepatoCellular carcinoma invasion of the gastrointestinal tract.
- Concurrent administration of interferon alfa-2b and beta-1a.
- Inaccurate glucose determination by fingerstick in a patient with peripheral arterial Disease.
- Severe Anemia and marrow plasmacytosis as presentation of Sjögren's syndrome.
- Hyperthermia and chronic pancerebellar Syndrome after cocaine abuse.
- Eligibility for outpatient treatment with low-molecular-weight heparin in venous thromboembolism.
Schools
Chulalongkorn University
Albert Einstein Medical Center
Stritch School of Medicine
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- AvMed
- Blue Card PPO
- Blue Care HMO
- BlueDental Choice
- NetworkBlue
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health Care
- Employer Group Open Access HMO
- Employer Group PPO
- Federal Employee Program (FEP)
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Harvard Pilgrim Health Care PPO
- Choice Care PPO
- Preferred PPO
- Select HMO
- Tampa Bay CoreNet
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- MVP Health Care
- Neighborhood Health Plan
- Tricare
- Choice Plus POS
- Neighborhood Health Partnership
- Options PPO
- United Healthcare
- WellCare
Education
-
Loyola University -
Albert Einstein Healthcare Network
Drug Facts
| NPI NUMBER | 1750303905 | |
| NPPES Provider LastName | TANVETYANON | |
| NPPES Provider FirstName | TAWEE | |
| NPPES Provider ZIPCode | 33613 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 598.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 108.0 | |
| Percent Opioid Claims | 18.06 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1750303905 |
| Last Name Of The Provider | TANVETYANON |
| First Name Of The Provider | TAWEE |
| View All |
Similar Doctors
|
Dr. Melissa Alsina, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Brian E. Cadigan, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Claudio Anasetti, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rand W. Altemose, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alan F. List, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William R. Dinwoodie, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Frederick Locke, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Eric Padron, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. William S. Dalton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ankita K. Shah, MD |
|
|
Dr. Saloomeh Vahdat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xiaohui C. Zhang, MD
This Doctor is OpenDoctor Recommended.
|